Preparing for your COVID-19 vaccination (Pfizer)

Preparing for your COVID-19 vaccination (Pfizer)

If you don’t have a Medicare Number you MUST contact Services Australia  and arrange an Individual Health Identifier Number and bring it to your Appointment.

This is to register your vaccination on the Government Register.

https://www.servicesaustralia.gov.au/individuals/services/medicare/individual-healthcare-identifiers

Please DOWNLOAD and READ the Following

Preparing for COVID-19 vaccination

https://www.health.gov.au/resources/publications/covid-19-vaccination-information-on-covid-19-pfizer-comirnaty-vaccine

PLEASE DOWNLOAD CONSENT FORM – PRINT and FILL IN (Bring to your Appointment)

Pfizer Covid-19 Vaccination Consent Form

DOSAGE

COVID-19 Vaccine
The recommended interval between two doses of COVID-19 Vaccine Pfizer is 3 weeks.
Additional or booster doses beyond the two-dose course are not currently recommended.
There should be a minimum interval of 7 days between receipt of a COVID-19 vaccine and any other vaccine

CO-ADMINISTRATION OF ANALGESICS / ANTIPYRETICS

Prophylactic use of paracetamol or ibuprofen is not recommended before receiving a COVID-19 vaccine. Antipyretics and analgesics can be taken after vaccination for management of vaccine-related side effects such as fever and myalgia, if required.

CONTRAINDICATIONS

The only absolute contraindications to a COVID-19 vaccine are: ∙ anaphylaxis after a previous dose of the same vaccine ∙ anaphylaxis to any component of the vaccine, including: ∙ anaphylaxis to polyethylene glycol (PEG) for Comirnaty ∙ anaphylaxis to polysorbate 80 for COVID-19 Vaccine AstraZeneca

Delay

  • people with a generalised allergic reaction (without anaphylaxis) to any component of the COVID-19 vaccine to be administered (e.g. PEG in Comirnaty or polysorbate 80 in COVID-19 Vaccine AstraZeneca)
  • people with a prior history of anaphylaxis to previous vaccines and/or multiple drugs (injectable and/or oral) where ingredients such as PEG or polysorbate 80 may conceivably be the cause
  • people with a known systemic mast cell activation disorder with raised mast cell tryptase that requires treatment.
  • Pregnancy


COVID-19 vaccination – COVID-19 vaccination decision guide for women who are pregnant, breastfeeding, or planning pregnancy | Australian Government Department of Health


If people in these categories are vaccinated, they may require vaccination in a facility with medical staff in attendance, and to be observed for 30 minutes following administration of a COVID-19 vaccine dose.

AFTER VACCINATION

After your COVID-19 vaccination (health.gov.au)